TargImmune Therapeutics

About:

TargImmune Therapeutics is focused on drug development using novel targeted onco-immunotherapies.

Website: https://www.targimmune.com/

Top Investors: EASME - EU Executive Agency for SMEs

Description:

TargImmune Therapeutics AG is a private Swiss-based biotechnology company focused on drug development using novel targeted onco-immunotherapies. The Company’s principal technology is the CTPIC technology platform that utilizes a non-viral vector to target and destroy cancer cells that over-express certain receptors while simultaneously eliciting an immune response against the cancer cells.